The growing influence of patients in selecting their treatment options and the emergence of risk-sharing agreements between drug manufacturers and payers have fundamentally changed the way pharmaceutical companies market and support their products.
In the past, pharmaceutical companies centered their efforts on provider education and winning support from payers to pay for new treatments.
In the new paradigm, companies must engage with multiple stakeholders throughout the patient journey to build demand, manage risk, and deliver results.
This new business model demands integration across functional areas that traditional data management systems cannot easily support. In this paper, we discuss the ten critical components of a modern Information Management Strategy for life sciences commercial operations.